Nalu Medical announced today that it closed a $65 million equity financing to support its minimally invasive neurostimulation product. Carlsbad, California–based Nalu had its round led by new investor Novo Holdings. All existing significant investors — including Gilde Healthcare, MVM Partners, Endeavor Vision, Decheng Capital, Longitude Capital, Advent Life Sciences, Pura Vida and Aperture Venture […]
Pain Management
SEC: former Stimwave CEO defrauded investors out of $41M with fake neuromod implant
The SEC charged Laura Perryman, former Stimwave CEO and co-founder, with defrauding investors out of approximately $41 million. Perryman founded and served as CEO of Florida-based Stimwave until her termination in 2019. In February 2020, Stimwave ceased all sales of its high-frequency spinal cord stimulation systems in exchange for the dismissal of a patent infringement lawsuit brought by […]
ShiraTronics reports first implants of minimally invasive implant for treating chronic migraine
ShiraTronics announced the successful implantation of its Chronic Migraine System in the world’s first six patients. Minneapolis-based ShiraTronics designed the neuromodulation system to address the debilitating symptoms of migraines. The company says it offers the first-ever fully implantable system for head location utilizing a minimally invasive approach. The fully implantable, programmable device delivers electrical pulses […]
ElectroCore expands nerve stimulation IP portfolio
ElectroCore (Nasdaq:ECOR) announced today that the U.S. Patent and Trademark office (USPTO) issued it a new nerve stimulation patent. The new patent (No. 11,839,764 ) relates to a system for stimulating a nerve target in the head or neck of a patient. It covers the treatment of various disorders, such as primary headache. It’s titled […]
Boston Scientific closes Relievant Medsystems acquisition
Boston Scientific announced today that it completed its previously announced acquisition of Relievant Medsystems. In September, Boston Scientific announced plans to acquire Relievant for an upfront cash payment of $850 million. Additional payments are contingent on sales performance over the next three years. Minneapolis-based Relievant developed and commercialized the Intracept intraosseous nerve ablation system for […]
Boston Scientific wins expanded indication for SCS system
The FDA has greenlit an expanded indication for the WaveWriter Alpha spinal cord stimulator systems from Boston Scientific . The approval now includes the treatment of painful diabetic peripheral neuropathy, a diabetes complication affecting the lower extremities. Diabetic neuropathy, a form of nerve damage often found in the legs and feet, is caused by prolonged […]
FDA approves next-gen intrathecal drug delivery system from Medtronic
Medtronic (NYSE:MDT) announced today that the FDA approved its next-generation SynchroMed III intrathecal drug delivery system. The medtech giant designed SynchroMed III to treat patients with chronic pain, cancer pain and severe spasticity. The targeted drug delivery (TDD) system alleviates symptoms by delivering medication directly to the fluid surrounding the spinal cord. SynchroMed III builds upon […]
Biotronik has positive data for its spinal cord stimulation tech
Biotronik today announced positive results from a clinical trial for its Neuro Prospera spinal cord stimulation (SCS) system. The BENEFIT-02 trial evaluates the Resonance multiphase stimulating paradigm used in the Neuro Prospera system. It looked at the safety and effectiveness of the stimulator in treating patients with chronic pain. Contrary to other currently available SCS […]
Relievant Medsystems unveils Intracept simulation training program
Relievant Medsystems announced today that it released its Intracept simulator system, a training platform for the Intracept procedure. Further progress for Relievant and Intracept follows Tuesday’s major news of an agreement for Boston Scientific to acquire the company. Boston Scientific officials went into further detail on their expectations for the Relievant deal at the company’s […]
Boston Scientific targets M&A, AI to reach ‘next level’
Mike Mahoney uses fantasy football to describe Boston Scientific : He says that, if creating a medtech team, “it would be the draft you want.” Speaking at the company’s 2023 Investor Day event, the CEO set the theme as “next level.” He explained his aim to make Boston Scientific a “compelling” and “fantastic place to […]
Boston Scientific to acquire nerve ablation tech developer Relievant Medsystems for $850M
Boston Scientific announced today that it entered into a definitive agreement to acquire Relievant Medsystems. The transaction includes an upfront cash payment of $850 million. Additional payments are contingent on sales performance over the next three years. Minneapolis-based Relievant developed and commercialized the Intracept intraosseous nerve ablation system for chronic pain. The minimally invasive, FDA-cleared, […]